The Nasdaq Biotechnology Index, an indicator of investor sentiment in an industry based on science, continued heading down during the third quarter of 2023.
I realise you may be fed up of #business news focussing on #shareprice indices (& I agree with you), but it is notable that this year the FTSE100 has significantly diverged from other major measures... again, you may be dismissive of the implied judgements of (largely institutional) #investors, but the comparison is telling;
investors clearly think all value is 'priced in' to UK stocks suggesting a pretty negative view of any ongoing economic growth.